Concepedia

Gary D. Pilcher

GD

Statistics

Publications

13

Citations

912

H-Index

12

Active since

1985

Affiliations

Bristol-Myers Squibb (United States)(Current)

Wright State University

Mallinckrodt (United States)

Gary D. Pilcher is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and engineering.

Top concepts

Publications per year

1985–2018

13

Publications

13

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway et al. · Archives of Neurology · 2012 · 363 citations

Targeting Prodromal Alzheimer Disease With Avagacestat

Vladimir Coric, Stephen Salloway, Christopher H. van Dyck et al. · JAMA Neurology · 2015 · 229 citations · Full text

Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat

Charles F. Albright, Randy Dockens, Jere E. Meredith et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 63 citations

Mechanism of the serum thyroid hormone lowering effect of perfluoro‐<i>n</i>‐decanoic acid (PFDA) in rats

Denise M. Gutshall, Gary D. Pilcher, Albert E. Langley · Journal of Toxicology and Environmental Health · 1989 · 56 citations

Thyroid, bradycardic and hypothermic effects of perfluoro‐n‐decanoic acid in rats

Albert E. Langley, Gary D. Pilcher · Journal of Toxicology and Environmental Health · 1985 · 45 citations

, , +13

1–5 of 13